AI-generated summary
This pilot study compared low-level laser therapy with a switched-off placebo device on one side of each patient's body in 12 people with type 2 diabetes and diabetic dermopathy, over one month. The authors report that lesion diameter and skin blood flow improved more on the laser side than on the placebo side. The sample was small and the abstract describes this as a pilot study.
- Participants
- 12
- Who or what was studied
- Patients with type 2 diabetes and bilateral diabetic dermopathy, aged 50 to 65 years (9 men, 3 women)
- Limits stated in the abstract
- The study was a small pilot with 12 patients, and the abstract does not report the laser wavelength.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Pilot study, Laser, Placebo-controlled. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.